Dupilumab in Inflammatory Skin Diseases: A Systematic Review

    March 2023 in “ Biomolecules ”
    Henning Olbrich, Christian D. Sadik, Ralf J. Ludwig … Katharina Boch
    Studysummary This study reviewed the use of dupilumab, beyond its approved indications for atopic dermatitis and prurigo nodularis, and found effective treatment reports for various chronic inflammatory skin diseases such as bullous autoimmune diseases, eczema, and alopecia areata, highlighting its broad potential in dermatology.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 8

    1. Improvement of Atopic Dermatitis and Alopecia Universalis with Dupilumab: A Case Report Dermatology reports · 2021
    2. Dupilumab-Induced Psoriasis in a Patient With Atopic Dermatitis and Alopecia Totalis: A Case Report and Literature Review Dermatologic Therapy · 2021
    3. Time to Loss of Response for Dupilumab in Ophiasis-Pattern Alopecia Areata JAAD case reports · 2021
    4. Dupilumab for the Treatment of Alopecia Areata in Children with Atopic Dermatitis JAAD case reports · 2021
    5. Dupilumab Therapy for Alopecia Areata in Pediatric Patients with Concomitant Atopic Dermatitis Journal of the American Academy of Dermatology · 2021
    6. Dupilumab And Alopecia: A Janus Effect Dermatologic Therapy · 2019
    7. Dupilumab Treatment for Atopic Dermatitis Leading to Unexpected Treatment for Alopecia Universalis JAAD case reports · 2019
    8. Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report Acta Dermato Venereologica · 2019